Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Manz, Markus G.
662  Ergebnisse:
Personensuche X
?
1

A novel strategy to generate immunocytokines with activity-..:

Rotta, Giulia ; Gilardoni, Ettore ; Ravazza, Domenico...
EMBO Molecular Medicine.  16 (2024)  4 - p. 904-926 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Historic characteristics and mortality of patients in the S..:

Brouwers, Sofie ; Heimgartner, Raphael ; Laptseva, Natallia...
Swiss Medical Weekly.  154 (2024)  2 - p. 3485 , 2024
Link: https://doi.org/10.57187..
 
?
3

Targeting the mevalonate or Wnt pathways to overcome CAR T-..:

Mueller, Jan ; Schimmer, Roman R ; Koch, Christian...
EMBO Molecular Medicine.  16 (2024)  3 - p. 445-474 , 2024
Link: https://doi.org/10.1038/..
 
?
4

Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic..:

Trepl, Julia ; Pasin, Chloé ; Schneidawind, Dominik...
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
5

Deciphering Factors Linked With Reduced Severe Acute Respir..:

Abela, Irene A ; Hauser, Anthony ; Schwarzmüller, Magdalena...
The Journal of Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
6

Intrapatient competition of VEXAS syndrome and CML clones:

Djerbi, Nadia ; Zimmermann, Kathrin ; Roncador, Marco...
Blood Advances.  7 (2023)  22 - p. 6815-6818 , 2023
Link: https://doi.org/10.1182/..
 
?
7

Age and sex associate with outcome in older AML and high ri..:

Hilberink, Jacobien R. ; van Zeventer, Isabelle A. ; Chitu, Dana A....
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
8

Selective tumor targeting enabled by picomolar fibroblast a..:

Puglioli, Sara ; Schmidt, Eleonore ; Pellegrino, Christian...
Chem.  9 (2023)  2 - p. 411-429 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Prognostic Significance of Measurable Residual Disease Dete..:

Tettero, Jesse M. ; Buisman, Yara ; Ngai, Lok Lam...
HemaSphere.  7 (2023)  12 - p. e981 , 2023
Link: https://doi.org/10.1097/..
 
?
10

Ex vivo drug response heterogeneity reveals personalized th..:

Kropivsek, Klara ; Kachel, Paul ; Goetze, Sandra...
Nature Cancer.  4 (2023)  5 - p. 734-753 , 2023
Link: https://doi.org/10.1038/..
 
?
11

Aging drives Tet2+/− clonal hematopoiesis via IL-1 signalin:

Caiado, Francisco ; Kovtonyuk, Larisa V. ; Gonullu, Nagihan G....
Blood.  141 (2023)  8 - p. 886-903 , 2023
Link: https://doi.org/10.1182/..
 
?
12

Chimeric antigen receptor T cell-based targeting of CD317 a..:

Hänsch, Lena ; Peipp, Matthias ; Mastall, Maximilian...
Neuro-Oncology.  25 (2023)  11 - p. 2001-2014 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Measurable residual disease-guided therapy in intermediate-..:

Tettero, Jesse M. ; Ngai, Lok Lam ; Bachas, Costa...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
14

Complication rates of peripherally inserted central cathete..:

Rieger, Max J. ; Schenkel, Xenia ; Dedic, Ivona...
International Journal of Cancer.  153 (2023)  7 - p. 1397-1405 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Prospective Validation of the Prognostic Relevance of CD34+..:

Ngai, Lok Lam ; Hanekamp, Diana ; Janssen, Fleur...
Blood.  , 2023
Link: https://doi.org/10.1182/..
 
1-15